Effects of statin use on intracranial hemorrhage and clinical outcome after intravenous rt-PA for acute ischemic stroke: SAMURAI rt-PA registry

Clinical Neurology

Volumn 50, Issue 4, 2010, Pages 225-231

  Makihara, Noriko ^a   Okada, Yasushi ^a   Koga, Masatoshi ^b   Shiokawa, Yoshiaki ^c   Nakagawara, Jyoji ^d   Furui, Eisuke ^e   Kimura, Kazumi ^f   Yamagami, Hiroshi ^g   Hasegawa, Yasuhiro ^h   Kario, Kazuomi ⁱ   Okuda, Satoshi ^j   Naganuma, Masaki ^b   Toyoda, Kazunori ^b  

^a NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Nakamura Memorial Hospital   (Japan)

^e KOHNAN HOSPITAL   (Japan)

^f KAWASAKI MEDICAL SCHOOL   (Japan)

^g KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^h ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ JICHI MEDICAL UNIVERSITY   (Japan)

^j NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

more..

Author keywords

Brain infarction; Dyslipidemia; Intracranial hemorrhage; Statin; Thrombolysis

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE REGISTRY; DRUG EFFECT; DYSLIPIDEMIA; FEMALE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 77952198706     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.50.225     Document Type: Article

References (19)

1. Amarenco P, Labreuche J, Lavallee P, et al. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004;35:2902-2909. (Pubitemid 39565192)
2. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559.
3. Marti-Fàbregas J. Gomis M, Arboix A, et al. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 2004;35:1117-1123. (Pubitemid 38543528)
4. Reeves MJ, Gargano JW, Luo Z, et al. Effect of pretreatment with statins on ischemic stroke outcomes. Stroke 2008;39:1779-1785.
5. Yoon SS, Dambrosia J, Chalela J, et al. Rising statin use and effect on ischemic stroke outcome. BMC Med 2004;2:4. (Pubitemid 39111874)
6. Álvarez-Sabin J, Huertas R, Quintana M, et al. Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 2007:38:1076-1078. (Pubitemid 46568478)
7. Toyoda K, Koga M, Naganuma M, et al. Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register. Stroke 2009;40:3591-3595.
8. Barber PA, Demchuk AM, Zhang J, et al. for the ASPECTS Study Group. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 2000;355:1670-1674.
9. Bang OY, Saver JL, Liebeskind DS, et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 2007;68:737-742. (Pubitemid 46667898)
10. Meier N, Nedeltchev K, Brekenfeld C, et al. Prior statin use, intracranial hemorrhage, and outcome after intraarterial thrombolysis for acute ischemic stroke. Stroke 2009;40:1729-1737.
11. Wang S, Lee SR, Guo SZ, et al. Reduction of tissue plasminogen activator-induced matrix metalloproteinase-9 by simvastatin in astrocytes. Stroke 2006;37:1910-1912. (Pubitemid 44297750)
12. Zhang L, Zhang ZG, Ding GL, et al. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat. Circulation 2005;112:3486-3494. (Pubitemid 43739565)
13. Essig M, Nguyen G, Prie D, et al. 3-Hydroxy-3 methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells: role of geranylgeranylation and Rho proteins. Circ Res 1998;83:683-690. (Pubitemid 28462781)
14. Georgiadis AL,Hussein HM, Vazquez G, et al. Premorbid use of statins is associated with higher recanalization rates in patients with acute ischemic stroke undergoing endovascular treatment. J Neuroimaging 2009;19:19-22.
15. Kimura K, Iguchi Y, Shibazaki K, et al. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients. J Neurol Sci 2008;270:48-52.
16. Amin-Hanjani S, Stagliano NE, Yamada M, et al. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 2001;32580-32986 (Pubitemid 32285170)
17. Laufs U, Gertz K, Huang P, et al. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 2000;31:2437-2449.
18. Blanco M, Nombela F, Castellanos M, et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 2007;69:904-910.
19. Newman GC, Bang H, Hussain SI, et al. Association of diabetes, homocysteine, and HDL with cognition and disability after stroke. Neurology 2007;69;2054-2062.